Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report

References

• Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes. 2009;1:9–17.
   PubMed Web of Science ®Google Scholar
• El-Agouza I, Abu SA, Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24:285–289.
   PubMedGoogle Scholar
• Jiao Y, Okumiya T, Saibara T. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care. 1998;21:1732–1735.
   PubMed Web of Science ®Google Scholar
• Speeckaert M, Van Biesen W, Delanghe J, et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. 2014;29:2167–2177.
   PubMed Web of Science ®Google Scholar
• Lachin JM, Orchard TJ, Nathan DM. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37:39–43.
   PubMed Web of Science ®Google Scholar
• Ricks J, Molnar MZ, Kovesdy CP, et al. Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes. 2012;61:708–715.
   PubMed Web of Science ®Google Scholar
• Duong U, Mehrotra R, Molnar MZ, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. CJASN. 2011;6:1041–1048.
   PubMed Web of Science ®Google Scholar
• Kuo IC, Lin HY, Niu SW, et al. Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease. PLoS One. 2018;13:e0199378.
   PubMed Web of Science ®Google Scholar
• Dozio E, Di Gaetano N, Findeisen P, et al. Glycated albumin: from biochemistry and laboratory medicine to clinical practice. Endocrine. 2017;55:682–690.
   PubMed Web of Science ®Google Scholar
• Bellia C, Zaninotto M, Cosma C, et al. Clinical usefulness of glycated albumin in the diagnosis of diabetes: results from an Italian study. Clin Biochem. 2018;54:68–72.
   PubMed Web of Science ®Google Scholar
• Wu WC, Ma WY, Wei JN, et al. Serum glycated albumin to guide the diagnosis of diabetes mellitus. PLoS One. 2016;11:e0146780.
   PubMed Web of Science ®Google Scholar
• Ikezaki H, Furusyo N, Ihara T, et al. Glycated albumin as a diagnostic tool for diabetes in a general Japanese population. Metab Clin Exp. 2015;64:698–705.
   PubMed Web of Science ®Google Scholar
• Lee EY, Lee BW, Kim D, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol. 2011;48:167–172.
   PubMed Web of Science ®Google Scholar
• Won HK, Kim KJ, Lee BW, et al. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments. Diabet Med. 2012;29:74–79.
   PubMed Web of Science ®Google Scholar
• Desouza CV, Rosenstock J, Zhou R, et al. Glycated albumin at 4 weeks correlates with A1c levels at 12 weeks and reflects short-term glucose fluctuations. Endocr Pract. 2015;21:1195–1203.
   PubMed Web of Science ®Google Scholar
• Bellia C, Zaninotto M, Cosma C, et al. Glycated albumin is correlated to insulin resistance and β-cell secretory function in subjects at risk of developing diabetes. Biochimica Clinica. 2018;42:234–239.
   Web of Science ®Google Scholar
• Huh JH, Kim KJ, Lee BW, et al. The relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance status. PLoS One. 2014;9:e89478.
   PubMed Web of Science ®Google Scholar
• Koga M, Hirata T, Kasayama S, et al. Body mass index negatively regulates glycated albumin through insulin secretion in patients with type 2 diabetes mellitus. Clin Chim Acta. 2015;438:19–23.
   PubMed Web of Science ®Google Scholar
• Bellia C, Zaninotto M, Cosma C, et al. Definition of the upper reference limit of glycated albumin in blood donors from Italy. Clin Chem Lab Med. 2017;56:120–125.
   PubMed Web of Science ®Google Scholar
• Selvin E, Warren B, He X, et al. Establishment of community-based reference intervals for fructosamine, glycated albumin, and 1,5-anhydroglucitol. Clin Chem. 2018;64:843–850.
   PubMed Web of Science ®Google Scholar
• Montagnana M, Paleari R, Danese E, et al. Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects. Clin Chim Acta. 2013;423:1–4.
   PubMed Web of Science ®Google Scholar
• Chen CW, Drechsler C, Suntharalingam P, et al. high glycated albumin and mortality in persons with diabetes mellitus on hemodialysis. Clin Chem. 2017;63:477–485.
   PubMed Web of Science ®Google Scholar
• Hoshino J, Hamano T, Abe M, et al. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018;33:1150–1158.
   PubMed Web of Science ®Google Scholar
• Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 2011. http://www.who.int/vmnis/indicators/haemoglobin/en/. Last access 29 August 2018.
   Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2017;40:S11–S24.
   PubMed Web of Science ®Google Scholar
• Borg R, Persson F, Siersma V, et al. Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database. Diabet Med. 2018; 35:1700–1706.
   PubMed Web of Science ®Google Scholar
• Maesa JM, Fernández-Riejos P, Mora CS, et al. Evaluation of Bio-Rad D-100 HbA1c analyzer against Tosoh G8 and Menarini HA-8180V. Pract Lab Med. 2016;5:57–64.
   PubMedGoogle Scholar
• Reynolds AN, Harper M, Venn BJ, et al. Glycated albumin is stable in plasma when exposed to common laboratory conditions and comparable when drawn from venous or capillary sites. J Clin Lab Anal. 2018;32(2)e22236.
   Web of Science ®Google Scholar
• Nathan DM, Steffes MW, Sun W, et al. Determining stability of stored samples retrospectively: the validation of glycated albumin. Clin Chem. 2011;57:286–290.
   PubMed Web of Science ®Google Scholar
• Hill CJ, Cardwell CR, Patterson CC, et al. Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit. Diabet Med. 2014;31:448–454.
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034–2047.
   PubMed Web of Science ®Google Scholar
• Wu J, Gale CP, Hall M, et al. Editor’s choice – impact of initial hospital diagnosis on mortality for acute myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovasc Care. 2018;7:139–148.
   PubMed Web of Science ®Google Scholar
• Agnello L, Bivona G, Novo G, et al. Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study. Scand J Clin Lab Invest. 2017;77:428–432.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, Wiedmeyer HM, Little RR, et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25:275–278.
   PubMed Web of Science ®Google Scholar
• Jung M, Warren B, Grams M, et al. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: results from the Atherosclerosis Risk in Communities Study. J Diabetes. 2018;10:276–285.
   PubMed Web of Science ®Google Scholar
• Gan T, Liu X, Xu G. Glycated albumin versus HbA1c in the evaluation of glycemic control in patients with diabetes and CKD. Kidney Int Rep. 2018;3:542–554.
   PubMed Web of Science ®Google Scholar
• Kim IY, Kim MJ, Lee DW, et al. Glycated albumin is a more accurate glycaemic indicator than haemoglobin A1c in diabetic patients with pre-dialysis chronic kidney disease. Nephrology. 2015;20:715–720.
   PubMed Web of Science ®Google Scholar
• Uzu T, Hatta T, Deji N, et al. Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c). Ther Apher Dial. 2009;13:89–94.
   PubMed Web of Science ®Google Scholar
• Konya J, Ng JM, Cox H, et al. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment. Diabet Med. 2013;30:1250–1254.
   PubMed Web of Science ®Google Scholar
• Bhonsle HS, Korwar AM, Kote SS, et al. Low plasma albumin levels are associated with increased plasma protein glycation and HbA1c in diabetes. J Proteome Res. 2012;11:1391–1396.
   PubMed Web of Science ®Google Scholar